1LIFE HEALTHCARE INC (ONEM)
US68269G1076 - Common Stock
Taking everything into account, ONEM scores 2 out of 10 in our fundamental rating. ONEM was compared to 118 industry peers in the Health Care Providers & Services industry. While ONEM seems to be doing ok healthwise, there are quite some concerns on its profitability. ONEM is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ONEM has reported negative net income.
In the past year ONEM has reported a negative cash flow from operations.
ONEM had negative earnings in each of the past 5 years.
ONEM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ONEM has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ONEM's Gross Margin of 17.36% is on the low side compared to the rest of the industry. ONEM is outperformed by 66.96% of its industry peers.
ONEM's Gross Margin has declined in the last couple of years.
ONEM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.88%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ONEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
ONEM has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ONEM has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.62, we must say that ONEM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.62, ONEM perfoms like the industry average, outperforming 49.57% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that ONEM is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, ONEM is doing good in the industry, outperforming 74.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.62 |
ROIC/WACCN/A
WACC8.55%
2.3 Liquidity
A Current Ratio of 2.09 indicates that ONEM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.09, ONEM is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
A Quick Ratio of 2.06 indicates that ONEM has no problem at all paying its short term obligations.
ONEM's Quick ratio of 2.06 is fine compared to the rest of the industry. ONEM outperforms 79.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.09 | ||
| Quick Ratio | 2.06 |
3. Growth
3.1 Past
ONEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.14%.
Looking at the last year, ONEM shows a very strong growth in Revenue. The Revenue has grown by 95.17%.
ONEM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.97% yearly.
EPS 1Y (TTM)-74.14%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-11.76%
Revenue 1Y (TTM)95.17%
Revenue growth 3Y42.97%
Revenue growth 5YN/A
Revenue growth Q2Q72.71%
3.2 Future
Based on estimates for the next years, ONEM will show a decrease in Earnings Per Share. The EPS will decrease by -0.45% on average per year.
Based on estimates for the next years, ONEM will show a very strong growth in Revenue. The Revenue will grow by 31.98% on average per year.
EPS Next Y-30.59%
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
EPS Next 5YN/A
Revenue Next Year70.69%
Revenue Next 2Y46.99%
Revenue Next 3Y38.98%
Revenue Next 5Y31.98%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ONEM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONEM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.15%
EPS Next 3Y-0.45%
5. Dividend
5.1 Amount
No dividends for ONEM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1LIFE HEALTHCARE INC
NASDAQ:ONEM (2/21/2023, 7:00:03 PM)
Premarket: 17.87 +1.4 (+8.5%)16.47
+0.46 (+2.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.37B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.09 | ||
| Quick Ratio | 2.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-74.14%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-30.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)95.17%
Revenue growth 3Y42.97%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y